ARCH Venture Partners
Venture Capital
Deep Science & Academic Spinouts
Seed
Early Stage
Deep Tech
- Headquarters
- Chicago, United States
- Website
- archventure.com
- AUM
- $9.4B
- Portfolio Companies
- 129
- Total Investments
- 171
- Last Investment
- May 2026
- Geographic Focus
- United States
Investment Thesis
Co-founds and backs deep science companies at the earliest stages, partnering directly with university researchers and scientists to commercialize breakthrough discoveries in life sciences, biotech, and deep tech.
Portfolio129
O
ONI
WB
Walden Biosciences
JT
Juno Therapeutics
![](Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease." name="description"/><meta content="GateBioscience" property="og:title"/><meta content="Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease." property="og:description"/><meta content="https://cdn.prod.website-files.com/651ef47f48428a3c2cd4108a/654c13fb532c4467e354569b_1005.svg)
![](Advancing treatments for patients with a history of kidney stones" name="description"/><meta content="Advancing treatments for patients with a history of kidney stones" property="og:description"/><meta content="https://cdn.prod.website-files.com/6732fa614d6226ee5805a1fe/67a9d65ffee217e76fe781e6_Layer_1%20(2).svg)
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account